Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy

NCT04885751 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Osteoarthritis
Ankylosing Spondylitis
Other Musculoskeletal Disorder
Gastric Ulcer
Enteritis
NSAID-Associated Gastropathy
NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy

Interventions

DRUG: Eupatilin
DRUG: Rebamipide

Sponsor

Seoul National University Boramae Hospital

Collaborators

[object Object]